Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LFSC

F/m Emerald Life Sciences Innovation ETF

Mar 06 • 04:00PM ET

34.52

-0.54 -1.55 %

Financial • Exchange Traded Fund • USA • NASD

Held by: NMBL

Category	US Equities - Factor & Thematic	Asset Type	Equities (Stocks)	Tags	Developed	Return% 1Y	46.30%	Total Holdings	40	Perf Week	-5.11%
Sponsor	F/m Investments	ETF Type		Tags	equity	Return% 3Y	-	AUM	91.74M	Perf Month	-2.58%
Fund Family		Bond Type		Tags	innovation	Return% 5Y	-	NAV/sh		Perf Quarter	-7.69%
Index	-	Average Maturity		Tags	healthcare	Return% 10Y		52W High	40.10 -13.92%	Perf Half Y	20.99%
Index Weighting		Commodity Type		Tags	biotechnology	Return% SI		52W Low	18.78 83.80%	Perf YTD	-5.73%
Active/Passive		Quant Type		Tags	medical	Flows% 1M	5.88%	Volatility	1.16% 1.86%	Perf Year	49.83%
Dividend TTM	-	ESG Type		Tags	pharmaceutical	Flows% 3M	8.00%	ATR (14)	0.76	Perf 3Y	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	5.06%	RSI (14)	35.35	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.39	Perf 10Y	-
Expense	0.54%	Growth/Value		SMA20	-4.05%	Flows% 3Y		Rel Volume	0.08	Prev Close	35.06
Inverse/Leveraged		Market Cap		SMA50	-4.93%	Flows% 5Y		Avg Volume	7.15K	Price	34.52
IPO	Oct 31, 2024	Option/Short	No / Yes	SMA200	12.53%	Trades		Volume	571	Change	-1.55%

Jan-22-26 12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
Jan-14-26 06:44AM	Travere Stock Slips After FDA Delays Review Of Key Kidney Drug (Benzinga)
Dec-31-25 11:00AM	Best-Performing Active ETFs of 2025 (Zacks)
Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

LFSC

F/m Emerald Life Sciences Innovation ETF

Upgrade your FINVIZ experience